Top Markets
#1 Seeker Seeker +131.55%
#2 MowCat MowCat +108.83%
#3 Helium Helium +94.89%
#4 AI XOVIA AI XOVIA +91.25%
#5 Pons Pons +48.34%
#6 UnifAI Network UnifAI Network +33.34%
#7 Zora Zora +25.69%
#8 Bounce Bounce +25.32%
#9 Zylo Ecosystem Zylo Ecosystem +21.51%
#10 pipedog pipedog +18.86%
Coin of the day
Seeker Seeker
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Classement en actions #11444
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Prix de l'action
$8.74
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$699.74M
Changement (1 jour)
-4.85%
Changement (1 an)
-2.29%
Pays
US
Échange BridgeBio Oncology Therapeutics Inc. (BBOT)

Catégorie

Healthcare
Historique du rendement du dividende pour BridgeBio Oncology Therapeutics Inc. (BBOT)
Le rendement du dividende (TTM) de BridgeBio Oncology Therapeutics Inc. (symbole boursier : BBOT) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de BridgeBio Oncology Therapeutics Inc. (BBOT) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH